1. Home
  2. DCBO vs OVID Comparison

DCBO vs OVID Comparison

Compare DCBO & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Docebo Inc.

DCBO

Docebo Inc.

HOLD

Current Price

$20.61

Market Cap

419.6M

Sector

N/A

ML Signal

HOLD

Logo Ovid Therapeutics Inc.

OVID

Ovid Therapeutics Inc.

HOLD

Current Price

$2.80

Market Cap

365.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DCBO
OVID
Founded
2016
2014
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
419.6M
365.5M
IPO Year
2020
2017

Fundamental Metrics

Financial Performance
Metric
DCBO
OVID
Price
$20.61
$2.80
Analyst Decision
Buy
Strong Buy
Analyst Count
9
5
Target Price
$32.00
$4.60
AVG Volume (30 Days)
119.7K
3.0M
Earning Date
05-08-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
3.90
EPS
N/A
N/A
Revenue
N/A
$7,252,000.00
Revenue This Year
$12.89
N/A
Revenue Next Year
$11.44
$19.34
P/E Ratio
$22.04
N/A
Revenue Growth
N/A
1181.27
52 Week Low
$14.39
$0.27
52 Week High
$33.69
$3.11

Technical Indicators

Market Signals
Indicator
DCBO
OVID
Relative Strength Index (RSI) 64.87 60.07
Support Level $20.20 $2.56
Resistance Level $22.96 $3.11
Average True Range (ATR) 1.03 0.15
MACD 0.40 -0.03
Stochastic Oscillator 95.87 55.68

Price Performance

Historical Comparison
DCBO
OVID

About DCBO Docebo Inc.

Docebo Inc is a provider of cloud-based learning management systems. The solutions provided by the company allow learning administrators to deliver scalable and flexible personalized learning experiences, from formal training to social learning to multiple internal, external, and blended audiences. The group provides an easy-to-use, configurable, and affordable learning platform with the end-to-end capabilities and critical functionality needed to train both internal and external workforces, partners, and customers. The majority of the revenue is derived from customers based in North America.

About OVID Ovid Therapeutics Inc.

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.

Share on Social Networks: